Home » Topics » BioWorld Science, Immune

BioWorld Science, Immune
RSS

Multinational clinical trial results for Zenapax

Feb. 21, 1997

Novel rapamycin derivatives reported by Novartis

Feb. 21, 1997

MedImmune's HPV vaccine enters phase I

Feb. 18, 1997

Peptide Therapeutics/SmithKline Beecham vaccine technology alliance

Feb. 18, 1997

Immunosuppressants discovered by Merck & Co.

Feb. 18, 1997

Positive phase I safety profile for Immunex's new product candidate

Feb. 14, 1997

Melatonin in immunity, aging and cancer

Feb. 12, 1997

U.S. patent issued for meningococcal B vaccine

Feb. 11, 1997

CEAPRO receives patent coverage for potential vaccine adjuvants

Feb. 7, 1997

Legionella vaccine described by U.S. researchers

Feb. 7, 1997

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...